Publications by authors named "Alexander Tepper"

Claim this Profile
P
Plasminogen activator inhibitors orchestrate the immunosuppressive tumor microenvironment in pancreatic cancer.
Chiara Falcomatà, Sebastian R Nielsen, Maximilian M Schaefer, Bhavya Singh, Alexander Tepper

bioRxiv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian cancer-derived IL-4 promotes immunotherapy resistance.
Gurkan Mollaoglu, Alexander Tepper, Chiara Falcomatà, Hunter T Potak, Luisanna Pia

Cell· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cells type 1 control the formation, maintenance, and function of tertiary lymphoid structures in cancer.
Raphaël Mattiuz, Jesse Boumelha, Pauline Hamon, Jessica Le Berichel, Abishek Vaidya, Alexander Tepper

bioRxiv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic aging promotes cancer by fueling IL-1⍺-driven emergency myelopoiesis.
Matthew D Park, Jessica Le Berichel, Pauline Hamon, C Matthias Wilk, Meriem Belabed, Alexander Tepper

Science· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical genetic control of cytokine signaling in CAR-T cells using lenalidomide-controlled membrane-bound degradable IL-7.
Michael C Kann, Emily M Schneider, Antonio J Almazan, Isabel C Lane, Amanda A Bouffard, Alexander Tepper

Leukemia· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies.
Aline Renneville, Jessica A Gasser, Daniel E Grinshpun, Pierre M Jean Beltran, Namrata D Udeshi, Alexander Tepper

Blood Cancer Discov· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide.
Max Jan, Irene Scarfò, Rebecca C Larson, Amanda Walker, Andrea Schmidts, Alexander Tepper

Sci Transl Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow-specific loss of induces myeloproliferative neoplasm with features resembling human myelofibrosis.
Anna Chorzalska, John Morgan, Nagib Ahsan, Diana O Treaba, Adam J Olszewski, Alexander Tepper

Blood· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK-ERK and NF-κB pathways in a model of chronic myeloid leukemia.
Anna Chorzalska, Nagib Ahsan, R Shyama Prasad Rao, Karim Roder, Xiaoqing Yu, Alexander Tepper

Mol Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia.
Anna Chorzalska, Javier Flores Kim, Karim Roder, Alexander Tepper, Nagib Ahsan

Stem Cells Dev· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis